Draft of EU export restriction for COVID-19 vaccines
Access to Medicine
Novavax and Inovio COVID-19 Vaccine Contracts Limit Prices Companies Can Charge for Their Products
One of the main objections to march-in rights and reasonable pricing clauses is the repeated assertion by NIH leadership that pharmaceutical companies would never agree to a partnership with the federal government that involves price constraints. This argument defies logic… Continue Reading
President Ursula von der Leyen on COVID-19 (Davos Agenda Week): “And now, the companies must deliver. They must honour their obligations.”
On Tuesday, 26 January 2021, Dr. Ursula von der Leyen, President of the European Commission delivered a special address at “Davos Agenda Week” devoting much of her speech to the European Union’s response to the COVID-19 pandemic. While President von… Continue Reading
EB 148: KEI’s statement on WHO’s Global Observatory on Health R&D
On Friday, 22 January 2021, Knowledge Ecology International delivered the following remarks on WHO”s Global Observatory on Health R&D at the 148th session of WHO’s Executive Board. At meetings of WHO governing bodies, non-State actors are limited to one minute… Continue Reading
WHO EB 148: KEI’s statement on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies
At the meeting of the World Health Organization’s 148th Executive Board, Knowledge Ecology International delivered the following remarks on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies on Friday, 22 January… Continue Reading
The European Commission-Curevac Advance Purchase Contract for a COVID-19 Vaccine
The European Commission has released a redacted version of a contract with Curevac for a COVID-19 vaccine. The vaccine uses mRNA technology, similar to the Pfizer and Moderna vaccines. The contract is severely redacted in some areas, but some information… Continue Reading
Letter from the People’s Vaccine Alliance and Health Action International to Dr. Tedros on C-TAP
On 21 January 2021 the People’s Vaccine Alliance and Health Action International (HAI) sent an open letter to Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), expressing concern about the lack of political support and reported progress… Continue Reading
EB 148: WHO’s COVID-19 Technology Access Pool (C-TAP) comes under scrutiny
On Tuesday, 19 January 2021, the World Health Organization’s (WHO) Executive Board discussed the COVID-19 response. In these discussions, Knowledge Ecology International (KEI), and Health Action International (HAI) expressed concerns over WHO’s leadership of the COVID-19 Technology Access Pool (C-TAP).… Continue Reading
WHO EB 148: Oral statement of Knowledge Ecology International on the COVID-19 response
At the virtual meeting of the World Health Organization’s 148th Executive Board, Knowledge Ecology International delivered the following remarks on the COVID-19 response (agenda item 14.1) on Tuesday, 19 January 2021. Non-state actors are limited to one minute statements. 148th… Continue Reading
KEI Comments to NIH on Exclusive and Co-Exclusive Licenses to Senti Bio
Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) on January 12, 2021 regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Chimeric Antigen Receptor (CAR) Therapies for the Treatment of FMS-Like… Continue Reading